Oral antiviral drugs in experimental herpes simplex keratitis
Open Access
- 1 December 1983
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 24 (6) , 888-891
- https://doi.org/10.1128/aac.24.6.888
Abstract
Chronic oral administration of acyclovir or bromovinyl deoxyuridine to rabbits did not prevent recurrence of virus shedding or clinical corneal disease, nor did it alter the clinical course of recurrences of ocular herpetic disease or result in the appearance of resistant virus in tears.This publication has 9 references indexed in Scilit:
- Herpes Simplex KeratitisOphthalmology, 1983
- Effect of Intensive Acyclovir Therapy during Artificial Reactivation of Latent Herpes Simplex VirusExperimental Biology and Medicine, 1983
- Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in miceAntimicrobial Agents and Chemotherapy, 1982
- Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapyAntimicrobial Agents and Chemotherapy, 1982
- EFFICACY OF ORAL ACYCLOVIR IN THE TREATMENT OF INITIAL AND RECURRENT GENITAL HERPESPublished by Elsevier ,1982
- Statistical Analysis of the Rate of Recurrence of Herpesvirus Ocular Epithelial DiseaseAmerican Journal of Ophthalmology, 1981
- Human Leukocyte Interferon for the Prevention of Recurrences of Herpetic KeratitisThe Journal of Infectious Diseases, 1976
- Clinical Evaluation of Trifluorothymidine in the Treatment of Herpes Simplex Corneal UlcersAmerican Journal of Ophthalmology, 1972
- Therapeutic Antiviral Action of 5-Trifluoromethyl-2′-deoxyuridine in Herpes Simplex KeratitisScience, 1964